Most of the women I see with significant perimenopausal sleep disruption have already asked for help. They have usually spoken with a primary care physician, sometimes a gynecologist, occasionally a psychiatrist. They have often received some combination of sleep hygiene advice, a short prescription for a sleep medication, a recommendation to try relaxation techniques, and the general reassurance that things will probably settle down with time.
None of this is necessarily wrong. Some of it is reasonable. The problem is that it often arrives without a coherent explanation of what is actually happening. That absence matters, because the mechanism should shape the treatment, and perimenopausal sleep disruption is rarely just a deficit of good habits.
Sleep Hygiene Is an Optimization, Not a Treatment
The most common mistake is a category error: sleep hygiene is an optimization, not a treatment.
Consistent wake time, reduced evening alcohol, thoughtful caffeine use, screen limitation, a cool dark room, and a bedroom that does not resemble a small electronics showroom can all help. These are useful conditions for sleep. They support a system that is otherwise capable of functioning.
They do not, by themselves, repair a system whose underlying biology has changed.
A woman whose sleep disruption is being driven by declining progesterone, fluctuating estrogen, thermoregulatory instability, and increased physiologic arousal is not primarily suffering from insufficient blackout curtains. The curtains may help. They are not the diagnosis.
When “practice better sleep hygiene” is the main intervention offered, the predictable result is demoralizing. The patient does the things. She avoids caffeine, limits screens, cools the room, buys the magnesium, develops opinions about weighted blankets, and still wakes at 3:17 a.m. with the alertness of a small woodland animal under threat. She then concludes either that she is doing it wrong or that her sleep is simply broken.
Neither conclusion is usually accurate. But neither is corrected by advice that never explained the problem in the first place.
The Issues That Often Go Under-Discussed
There are several issues that commonly go under-discussed.
CBT-I Is Not Sleep Hygiene in Better Clothing
The first is cognitive behavioral therapy for insomnia, generally known as CBT-I. This is not a rebranded version of sleep hygiene, though it is often described that way, which is unhelpful bordering on sabotage.
CBT-I is a structured treatment for chronic insomnia. It targets the behavioral and cognitive patterns that maintain insomnia once it has developed. The central components typically include sleep restriction, which deliberately narrows and consolidates the sleep window to rebuild sleep pressure; stimulus control, which re-establishes the bed as a cue for sleep rather than wakefulness, effort, and frustration; and cognitive restructuring, which addresses the catastrophic thinking that often develops around sleep.
That last part matters. After enough bad nights, insomnia stops being only a nighttime problem. It becomes anticipatory. The patient begins monitoring the evening, negotiating with the clock, calculating how ruined tomorrow will be, and treating each awakening as evidence that the night has already failed. The nervous system is not soothed by this process. It tends to take notes.
The evidence for CBT-I in menopausal and perimenopausal insomnia is meaningful. It is not glamorous, and it does not sound as biologically satisfying as replacing a missing hormone, but it is one of the best-supported treatments we have for chronic insomnia. The referral rate, unfortunately, remains unimpressive. Many women who would benefit from CBT-I have never been told what it is, much less offered access to it.
Hormonal Therapy Belongs in the Conversation
The second issue is hormonal therapy, specifically as it relates to sleep.
This conversation is often narrower than it should be. Many women are told that menopausal hormone therapy may help hot flashes. Fewer are given a serious discussion of sleep disruption as a clinically relevant reason to consider it.
Estrogen affects sleep through several plausible and clinically relevant pathways. It influences serotonergic and noradrenergic systems involved in sleep regulation; it contributes to thermoregulation; and its fluctuation during perimenopause can fragment sleep even before menstruation has fully stopped. Progesterone also matters. Through its metabolite allopregnanolone, progesterone has GABAergic effects that can promote calm and sleep continuity. As progesterone declines, that stabilizing effect may diminish.
This does not mean that hormone therapy is appropriate for every woman with poor sleep in perimenopause. It is not. The decision depends on age, timing, symptoms, medical history, breast cancer risk, thrombotic risk, cardiovascular risk, uterine status, migraine history, medication interactions, and the patient’s goals. Medicine, annoyingly, continues to require medicine.
But the conversation is worth having. Sleep disruption is not a trivial quality-of-life footnote. Persistent insomnia affects mood, cognition, pain sensitivity, metabolic health, relationships, work performance, and the patient’s basic sense of being able to inhabit her own life. If hormonal instability is a major driver, pretending the problem is mainly behavioral is not clinically serious.
Sleep Apnea Should Not Be Missed
The third issue is sleep apnea.
This is routinely missed in women, especially in midlife. After menopause, the prevalence of obstructive sleep apnea in women rises substantially and begins to approach that seen in men. During the menopausal transition, the risk increases as well.
The problem is that women with sleep apnea often do not present with the stereotype. They may not describe heroic snoring, dramatic witnessed apneas, or a bed partner fleeing to another room in existential defeat. Many present with insomnia, frequent awakenings, fatigue, mood symptoms, morning headaches, cognitive fog, or non-restorative sleep. In other words, sleep apnea may look like “just perimenopause,” and perimenopause may provide a convenient explanation that prevents anyone from looking further.
That distinction matters because untreated sleep apnea is not simply poor sleep. It can contribute to sympathetic activation, blood pressure elevation, cardiovascular risk, mood disruption, cognitive complaints, and persistent daytime impairment. In a woman with sleep maintenance insomnia, unrefreshing sleep, daytime sleepiness or fatigue, morning headaches, snoring, witnessed apneas, worsening sleep in midlife, or treatment-resistant insomnia, sleep apnea should at least enter the conversation.
The Clinical Visit Should Produce a Model and a Plan
The practical version is this: the clinical visit should produce a model and a plan.
The useful questions are not complicated. Is there evidence that hormonal fluctuation is driving this sleep disruption? Is menopausal hormone therapy worth discussing, given the patient’s risks and goals? Has CBT-I been offered, or at least explained accurately? Is there any reason to evaluate for sleep apnea? Are medications helping, merely sedating, or quietly creating a new problem? Is alcohol being used as a sleep aid, and if so, is it worsening sleep fragmentation later in the night? Is the patient anxious because she cannot sleep, or unable to sleep because the bed has become a conditioned arena for vigilance?
These are not academic distinctions. They change treatment.
For some women, the right next step is CBT-I. For others, it is a hormone discussion with a clinician who understands menopause. For some, it is a sleep study. For many, it is a combination: stabilize the biology where appropriate, treat the conditioned insomnia that developed around it, and stop pretending that the bedroom temperature was the central plot all along.
When Waiting Is Not a Plan
The reassurance that perimenopause eventually ends is sometimes true and sometimes useful. Some women do improve on the other side of the transition. But persistent sleep disruption that lasts three months or longer, impairs daytime function, produces significant anxiety about sleep, or remains resistant to basic measures is not merely a waiting problem.
It is a clinical problem. More importantly, it is often a treatable one.
The first step is not another list of tips. It is a better explanation.
